FDA & PARGi

IDEAYA Receives Fast Track Designation for Potential First-in-Class PARG Inhibitor, IDE161, for Treatment of Pretreated, Platinum-Resistant Advanced or Metastatic Ovarian Cancer Patients having tumours with BRCA1/2 Mutations

https://tinyurl.com/bdhy2uuj

Defective DNA repair is important as a cause for ovarian cancer and the prevention of cancer elimination once established. Personalised treatment using PARP inhibitors acts by blocking alternative repair pathways through a process called synthetic lethality. 

Unfortunately resistance to PARPi is inevitable. Often this occurs because another repair process becomes active. One such process is Poly (ADP-ribose) Glycohydralase (PARG). A new Drug IDE161 has been developed to inhibit this repair process in a similar manner to PARPi.

The FDA has given Fast Track approval for this drug as a preliminary to full access. Usually this implies the FDA has confidence that the new treatment for those women with ovarian cancer, who have become resistant, will have a good outcome. With time it may be that the role of PARGi expands to become an alternative to PARPi as maintenance therapy.



Comments

Post a Comment

Popular posts from this blog

An impossible dream?

Image
Reducing ovarian cancer mortality through screening: an impossible dream? https://tinyurl.com/4524jh8f The history of screening tests for ovarian cancer is not good. Two huge trials; the UKCTOCS with  more than 200,000 recruits over 20 years and the PLCO trial with more than 3 million pathology samples  sho wed no benefit in terms of survival from ovarian cancer. This article addresses the stages of ovarian cancer using  an alternative approach called the clinical continuum,  which divides cancer into 3 phases ,  no disease, pre-clinical  (detectable disease) , and  clinical (overt cancer). Obviously for a screening test to be effective ,   cancer needs to be detected before the clinical  phase. However, ovarian cancer is unlike other cancer in that the precursor occurs in the fallopian tube and the re is an argument to say that ,  by the time ovarian cancer has occurred ,  it is always advanced and metastatic .   T his time in...
Read more

Sugar doesn’t feed cancer

Image
Revisiting the Warburg-Based “Sugar Feeds Cancer” Hypothesis: A Critical Appraisal of Epidemiological, Experimental and Mechanistic Evidence https://tinyurl.com/3v2tysdt Many clinical care professionals receive queries from cancer patients about whether they should modify their diet to red u ce consumed sugar. This concern is based on a misunde r standing of some basic medical research known as the Warbur g effect. Research from 1956 show ed that cancer cells alter their metaboli sm to enable increased glucose uptake and increase energy production. A misunderstanding of this effect has led to incorrect dietary advice to cancer patients suggesting sugar restriction may be benefi cial. As a result, malnutrition , which is already a s i gnificant cause of morbidity for cancer patients , can be exacerbated . No hard evidence that low sugar diets alter survival exists. Some anecdotal reports suggest a slight correlation with risk. This study is a n appraisal of all credible re...
Read more

Natural selection causing drug resistance

Image
Tracking clonal evolution during treatment in ovarian cancer using cell-free DNA https://tinyurl.com/2xtv64nx Drug resistance is the major cause of death from ovarian cancer. Why this occurs is problematic and varies with individuals. This s tudy looks at the evolving genetic mutations which cause previously effective chemo to lose its ability to control the cancer. Using new sequence genetic profiling of circulating tumour DNA , this prospective study followed the course of disease for 18 women with ovarian cancer from diagnosis to recurrence. The main finding was that the genetic clone s which disabled the chemo response w ere present at diagnosis for all these women . This suggests that evolutional preselection is occurring , whereby the environment of chemo promotes the increase in effectiveness of harmful genetic clone s . The authors suggest that understanding this evolutionary effect should lead to a  change in management, alter the environment, and prevent the...
Read more